KD Logo

BCRX (Biocryst Pharmaceuticals Inc) may reap gains as insiders became active recently

Biocryst Pharmaceuticals Inc’s filing revealed that its Director Hutson Nancy J unloaded Company’s shares for reported $52780.0 on Dec 13 ’24. In the deal valued at $7.54 per share,7,000 shares were sold. As a result of this transaction, Hutson Nancy J now holds 86,638 shares worth roughly $0.72 million.

Then, Hutson Nancy J bought 7,000 shares, generating $52,584 in total proceeds.

Before that, McKee Amy E sold 8,600 shares. Biocryst Pharmaceuticals Inc shares valued at $54,352 were divested by the Director at a price of $6.32 per share. As a result of the transaction, McKee Amy E now holds 27,831 shares, worth roughly $0.23 million.

Wedbush initiated its Biocryst Pharmaceuticals Inc [BCRX] rating to an Outperform in a research note published on February 25, 2025; the price target was $15. RBC Capital Mkts also remained covering BCRX and has increased its forecast on September 18, 2023 with a “an Outperform” recommendation from previously “Sector perform” rating. Jefferies revised its rating on August 04, 2023. It rated BCRX as “a Buy” which previously was an “a Hold”.

Price Performance Review of BCRX

On Tuesday, Biocryst Pharmaceuticals Inc [NASDAQ:BCRX] saw its stock fall -0.12% to $8.28. Over the last five days, the stock has lost -11.54%. Biocryst Pharmaceuticals Inc shares have risen nearly 10.11% since the year began. Nevertheless, the stocks have risen 42.27% over the past one year. While a 52-week high of $9.50 was reached on 02/21/25, a 52-week low of $4.03 was recorded on 01/17/25. SMA at 50 days reached $8.01, while 200 days put it at $7.45.

Levels Of Support And Resistance For BCRX Stock

The 24-hour chart illustrates a support level at 8.00, which if violated will result in even more drops to 7.71. On the upside, there is a resistance level at 8.50. A further resistance level may holdings at 8.72. The Relative Strength Index (RSI) on the 14-day chart is 46.57, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.28, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 77.96%. Stochastics %K at 48.18% indicates the stock is a holding.

Most Popular